The Novogene UK Genomic Sequencing Center will be equipped with a full automation system, and the latest illumina NovaSeq and super computing platforms. Establishing this facility will enable Novogene to provide cutting edge next-generation sequencing and bioinformatics services and solutions to scientists at European universities, research institutes, pharmaceutical companies and biotechnology companies.
“We are proud to set up our first European Laboratory at the Babraham Research Campus," said Dr. Ruiqiang Li, Founder and CEO of Novogene. “Our UK lab is our first step towards addressing the increasing demand for our European customers, and will help us contribute to advancing human health, environmental protection, and plant and animal breeding in the United Kingdom and the whole of Europe.”
Derek Jones, CEO Babraham Bioscience Technologies, which is responsible for the management and development of the Babraham Research Campus added: “I am extremely pleased to welcome Novogene to the Babraham Research Campus. The role of genomics is rapidly evolving and the Cambridge Cluster has become a hub for innovation in this area, attracting leading organisations, like Novogene, to locate here. Close proximity to academic and commercial collaborators - both on campus and within the wider cluster - is hugely beneficial to the organisations based here and results in innovative and ground-breaking research that will ultimately benefit us all.”
About Novogene
Novogene is a leading provider of genomic services and solutions with cutting-edge NGS and bioinformatics expertise and the largest sequencing capacity in the world. Novogene utilizes scientific excellence, a commitment to customer service and unsurpassed data quality to help our clients realize their research goals in the rapidly evolving world of genomics. With 1,800 employees, multiple branches around the world, 49 NGS-related patents, as well as over 950 publications in top-tier journals such as Nature and Science, the company has rapidly become a world leader in NGS services. For more information, visit http://en.novogene.com/.